Posts tagged Novartis

Pharmas collaborating increasingly with universities. Novartis and the University of Pennsylvania announced a research and licensing agreement that aims to bring to market a new approach to fighting cancer that has shown promising results in early trials.

Novartis expands its relationship with Walgreens to include clinical trials.

Sad news continues for pharmaceutical companies. Three leading pharmaceutical companies announced disappointing news from clinical tests on drugs they had hoped would turn out to be big sellers.

Roche vs. Novartis! Roche Holding AG will pay as much as $490 million for experimental drugs from PTC Therapeutics Inc. to treat a genetic muscle-weakening disease, in a deal that sets up a race with rival Novartis AG.

IBM and Novartis announced the NCD Challenge, a competition among a number of the world’s leading universities designed to tap the inventiveness of students to find new ways to address the rise of non-communicable diseases in both developing and developed countries.

Pfizer’s campaign to promote Lyrica is part of a stepped-up arms race among Western drug makers for a bigger presence in Japan, the world’s second-largest pharmaceuticals market after the U.S., with about $100 billion in yearly sales.